Wipfli Financial Advisors Llc, Biotechnology

Wipfli Financial Advisors Llc,

$1.42 Billion
Q3 2022

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$116B	$745,000 0.05% of portfolio	2,572	Q3 2022 New
NVO Novo Nordisk A S	$238B	$651,000 0.05% of portfolio	6,534	Q3 2022 New
REGN Regeneron Pharmaceuticals, Inc.	$79.7B	$555,000 0.04% of portfolio	805	Q3 2022 New
MRNA Moderna, Inc.	$14.5B	$360,000 0.03% of portfolio	3,045	Q3 2022 New
UTHR United Therapeutics Corp	$16.6B	$195,000 0.01% of portfolio	932	Q3 2022 New
GMAB Genmab A/S	$13.5B	$171,000 0.01% of portfolio	5,313	Q3 2022 New
TECH Bio Techne Corp	$2.7B	$149,000 0.01% of portfolio	526	Q3 2022 New
ALNY Alnylam Pharmaceuticals, Inc.	$30.6B	$122,000 0.01% of portfolio	611	Q3 2022 New
JAZZ Jazz Pharmaceuticals PLC	$7.47B	$108,000 0.01% of portfolio	812	Q3 2022 New
ARGX Argenx Se	$32.7B	$90,000 0.01% of portfolio	254	Q3 2022 New
SGEN Seagen Inc.	$0	$79,000 0.01% of portfolio	574	Q3 2022 New
BMRN Biomarin Pharmaceutical Inc	$11.6B	$72,000 0.01% of portfolio	844	Q3 2022 New
INCY Incyte Corp	$15.8B	$69,000 0.0% of portfolio	1,036	Q3 2022 New
AKBA Akebia Therapeutics, Inc.	$329M	$63,000 0.0% of portfolio	200,000	Q3 2022 New
HALO Halozyme Therapeutics, Inc.	$6.37B	$60,000 0.0% of portfolio	1,519	Q3 2022 New
ASND Ascendis Pharma A/S	$6.94B	$53,000 0.0% of portfolio	511	Q3 2022 New
EXEL Exelixis, Inc.	$11.2B	$46,000 0.0% of portfolio	2,930	Q3 2022 New
CYTK Cytokinetics Inc	$4.69B	$45,000 0.0% of portfolio	935	Q3 2022 New
MRTX Mirati Therapeutics, Inc.	$0	$42,000 0.0% of portfolio	600	Q3 2022 New
CRSP Crispr Therapeutics Ag	$3.69B	$41,000 0.0% of portfolio	630	Q3 2022 New
ARWR Arrowhead Pharmaceuticals, Inc.	$1.98B	$39,000 0.0% of portfolio	1,191	Q3 2022 New
INVA Innoviva, Inc.	$1.33B	$34,000 0.0% of portfolio	2,903	Q3 2022 New
ACAD Acadia Pharmaceuticals Inc	$2.63B	$33,000 0.0% of portfolio	2,009	Q3 2022 New
IONS Ionis Pharmaceuticals Inc	$5.02B	$27,000 0.0% of portfolio	619	Q3 2022 New
NTLA Intellia Therapeutics, Inc.	$997M	$25,000 0.0% of portfolio	455	Q3 2022 New
VERU Veru Inc.	$50.5M	$25,000 0.0% of portfolio	2,161	Q3 2022 New
VIR Vir Biotechnology, Inc.	$894M	$25,000 0.0% of portfolio	1,315	Q3 2022 New
MDXG Mimedx Group, Inc.	$1.03B	$23,000 0.0% of portfolio	8,000	Q3 2022 New
SRPT Sarepta Therapeutics, Inc.	$9.71B	$23,000 0.0% of portfolio	204	Q3 2022 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.17B	$22,000 0.0% of portfolio	1,677	Q3 2022 New
BEAM Beam Therapeutics Inc.	$1.72B	$21,000 0.0% of portfolio	438	Q3 2022 New
BHVN Biohaven Pharmaceutical Holding CO Ltd.	$3.36B	$19,000 0.0% of portfolio	124	Q3 2022 New
SAGE Sage Therapeutics, Inc.	$292M	$17,000 0.0% of portfolio	422	Q3 2022 New
FMTX Forma Therapeutics Holdings, Inc.	$958M	$16,000 0.0% of portfolio	800	Q3 2022 New
RPRX Royalty Pharma PLC	$11.5B	$16,000 0.0% of portfolio	404	Q3 2022 New
NVAX Novavax Inc	$630M	$15,000 0.0% of portfolio	841	Q3 2022 New
LGND Ligand Pharmaceuticals Inc	$1.88B	$14,000 0.0% of portfolio	160	Q3 2022 New
CORT Corcept Therapeutics Inc	$6.01B	$13,000 0.0% of portfolio	501	Q3 2022 New
DNA Ginkgo Bioworks Holdings, Inc.	$8.19B	$13,000 0.0% of portfolio	4,018	Q3 2022 New
KRTX Karuna Therapeutics, Inc.	$0	$13,000 0.0% of portfolio	56	Q3 2022 New
VNDA Vanda Pharmaceuticals Inc.	$277M	$13,000 0.0% of portfolio	1,342	Q3 2022 New
ATRA Atara Biotherapeutics, Inc.	$1.01B	$12,000 0.0% of portfolio	3,079	Q3 2022 New
ALBO Albireo Pharma, Inc.	$0	$11,000 0.0% of portfolio	564	Q3 2022 New
RCUS Arcus Biosciences, Inc.	$1.05B	$11,000 0.0% of portfolio	424	Q3 2022 New
FATE Fate Therapeutics Inc	$215M	$11,000 0.0% of portfolio	498	Q3 2022 New
RARE Ultragenyx Pharmaceutical Inc.	$3.25B	$11,000 0.0% of portfolio	268	Q3 2022 New
AGEN Agenus Inc	$4.73B	$10,000 0.0% of portfolio	5,076	Q3 2022 New
AKRO Akero Therapeutics, Inc.	$1.42B	$10,000 0.0% of portfolio	287	Q3 2022 New
GBT Global Blood Therapeutics, Inc.	$4.62B	$10,000 0.0% of portfolio	145	Q3 2022 New
NKTR Nektar Therapeutics	$187M	$10,000 0.0% of portfolio	3,084	Q3 2022 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wipfli Financial Advisors Llc,, based on Form 13F filings with the SEC.

News

Stay updated on Wipfli Financial Advisors Llc, with notifications on news.